Bone marrow endothelial cells produce osteoprotegerin: Evidence for a role in the development of myeloma bone disease

被引：0
|
作者：
De Leenheer, E
Vanderkerken, K
Mueller, G
Shipman, C
Bakkus, M
Van Camp, B
Croucher, P
机构：
[1] Univ Sheffield, Div Clin Sci, Sch Med, Sheffield, S Yorkshire, England
[2] Free Univ Brussels, Brussels, Belgium
[3] Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford, England
[4] Free Univ Brussels, Acad Hosp, Mol Haematol Lab, B-1090 Brussels, Belgium
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1033 / 1033
页数：1
相关论文
共 50 条
  • [1] Osteoprotegerin and the development of myeloma bone disease
    Croucher, P
    Shipman, C
    Vanderkerken, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1565 - 1565
  • [2] Bone marrow endothelial cells express the osteoclastogenic factor RANKL and its decoy receptor OPG: Evidence for a role in the development of myeloma bone disease.
    De Leenheer, E
    Vanderkerken, K
    Bakkus, M
    Van Camp, B
    Shipman, C
    Croucher, P
    BLOOD, 2002, 100 (11) : 209A - 209A
  • [3] Evidence of a role for RANKL in the development of myeloma bone disease
    De Leenheer, E
    Mueller, GS
    Vanderkerken, K
    Croucher, PI
    CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (04) : 340 - 346
  • [4] Endothelial cells in the bone marrow of patients with multiple myeloma
    Vacca, A
    Ria, R
    Semeraro, F
    Merchionne, F
    Coluccia, M
    Boccarelli, A
    Scavelli, C
    Nico, B
    Gernone, A
    Battelli, F
    Tabilio, A
    Guidolin, D
    Petrucci, MT
    Ribatti, D
    Dammacco, F
    BLOOD, 2003, 102 (09) : 3340 - 3348
  • [5] Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
    Croucher, PI
    Shipman, CM
    Perry, M
    Lippitt, J
    Asosingh, K
    van Beek, EJR
    Van Camp, B
    Russell, RGG
    Dunstan, C
    Vanderkerken, K
    BONE, 2001, 28 (05) : S81 - S81
  • [6] Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
    Croucher, PI
    Shipman, CM
    Lippitt, J
    Perry, M
    Asosingh, K
    Hijzen, A
    Brabbs, AC
    van Beek, EJR
    Holen, I
    Skerry, TM
    Dunstan, CR
    Russell, GR
    Van Camp, B
    Vanderkerken, K
    BLOOD, 2001, 98 (13) : 3534 - 3540
  • [7] Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment
    Giuliani, N
    Bataille, R
    Mancini, C
    Lazzaretti, M
    Barillé, S
    BLOOD, 2001, 98 (13) : 3527 - 3533
  • [8] Myeloma bone disease: A vicious cycle by interactions between myeloma cells and bone marrow cells
    Matsumoto, T.
    Abe, M.
    CANCER TREATMENT REVIEWS, 2006, 32 : S23 - S23
  • [9] Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease
    Croucher, PI
    Shipman, CM
    Van Camp, B
    Vanderkerken, K
    CANCER, 2003, 97 (03) : 818 - 824
  • [10] RANK ligand and osteoprotegerin in myeloma bone disease
    Sezer, O
    Heider, U
    Zavrski, I
    Kühne, CA
    Hofbauer, LC
    BLOOD, 2003, 101 (06) : 2094 - 2098
12345